Tumor treating fields in malignant pleural mesothelioma: from cytoskeletal collapse to immunophenotypic conversion. [PDF]
Ma X, Zuo Z, Sun Y, An H.
europepmc +1 more source
Comorbidity Burden in Lung Cancer and Malignant Pleural Mesothelioma: Nationwide Database Results of Turkey. [PDF]
Özdilekcan Ç +9 more
europepmc +1 more source
Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report. [PDF]
Otsuka S, Hiraoka K, Iwashiro N.
europepmc +1 more source
Correction to 'Cul4A is an oncogene in malignant pleural mesothelioma'. [PDF]
europepmc +1 more source
PD-L1 and BAP1 as Prognostic Biomarkers in Malignant Pleural Mesothelioma. [PDF]
Gajić M +15 more
europepmc +1 more source
Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study. [PDF]
Aydin O +15 more
europepmc +1 more source
Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma. [PDF]
Kano M +7 more
europepmc +1 more source
Multi-omics integration reveals tumor and microenvironmental heterogeneity in malignant pleural mesothelioma. [PDF]
Hu H, Li L, Bian W, Wu X.
europepmc +1 more source
Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort study. [PDF]
Avilés-Salas A +12 more
europepmc +1 more source
Solitary Malignant Pleural Mesothelioma: A Rare Presentation. [PDF]
Wang F, Wang H.
europepmc +1 more source

